top of page
Video
Learn more about the Targeted Two-Drug Combo Therapy.
Prototypes
The prototype above represents the Targeted Two-Drug Combo Therapy, a liposome surrounded by pegylated lipids and monoclonal antibodies, with metformin and 2DG in its core. To the left is the exterior of the technology. To the right is its interior.
The prototype above presents an up-close picture of a monoclonal antibody, a key component of the Targeted Two-Drug Combo Therapy.
bottom of page